Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
BayCysLT2 is a cysteinyl leukotriene 2 (CysLT2) receptor antagonist (IC50 = 53 nM).1 It selectively inhibits calcium mobilization induced by leukotriene D4 (LTD4; Item No. 20310) in HEK293 cells expressing human CysLT2 receptors over HEK293 cells expressing CysLT1 receptors when used at a concentration of 100 nM. BayCysLT2 reverses LTC4-induced increases in coronary artery perfusion pressure and decreases in contractility in isolated perfused guinea pig hearts.2 In vivo, BayCysLT2 (3 mg/kg) reduces infarct volume in a human CysLT2 receptor transgenic mouse model of myocardial ischemia and reperfusion injury induced by left anterior descending coronary artery (LAD) ligation.1
WARNING This product is not for human or veterinary use.
1. A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice. J. Pharmacol. Exp. Ther. 339(3), 768-778 (2011).
2. Isophtalic acid derivatives. US20060154912A1, (2006).